LIGAND PHARMACEUTICALS INC Insider Trading for May 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for May 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 622 | 0 | 27,244 | 26.6 K to 27.2 K (+2.34 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 622 | 0 | 38,647 | 38 K to 38.6 K (+1.64 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 188 | 0 | 20,290 | 20.1 K to 20.3 K (+0.94 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 622 | 0 | 20,102 | 19.5 K to 20.1 K (+3.19 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 622 | 0 | 44,333 | 43.7 K to 44.3 K (+1.42 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 188 | 0 | 56,209 | 56 K to 56.2 K (+0.34 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 622 | 0 | 56,021 | 55.4 K to 56 K (+1.12 %) |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 622 | 0 | 58,959 | 58.3 K to 59 K (+1.07 %) |
May 19 2016 | LGND | LIGAND PHARMACEUTI ... | Herman Melanie J | Director of Account ... | Sell | S | 120.50 | 334 | 40,247 | 3,297 | 3.6 K to 3.3 K (-9.20 %) |
May 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 118.52 | 15,000 | 1,777,833 | 210,707 | 225.7 K to 210.7 K (-6.65 %) |
May 09 2016 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Sell | S | 120.21 | 10,000 | 1,202,121 | 225,707 | 235.7 K to 225.7 K (-4.24 %) |
May 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 122.04 | 200 | 24,408 | 43,711 | 43.9 K to 43.7 K (-0.46 %) |
May 03 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 121.45 | 800 | 97,160 | 43,911 | 44.7 K to 43.9 K (-1.79 %) |